Ababax Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 7

Employees

  • Latest Deal Type
  • M&A

Ababax General Information

Description

Manufacturer of digital drug delivery products designed to treat depression, anxiety, myopia and cognitive decline. The company specializes in non-invasive brain stimulation technologies delivered via consumer devices such as a standard smartphone using the findings from neuroscience, machine learning and psychology, thereby helping to alter the communication between neuron populations and brain regions.

Contact Information

Website
www.ababax.health
Formerly Known As
FH Venture BII GmbH
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Friedrichstraße 68
  • 10117 Berlin
  • Germany
Primary Industry
Drug Delivery
Acquirer
Eternity.Health
Vertical(s)
Life Sciences
Corporate Office
  • Friedrichstraße 68
  • 10117 Berlin
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ababax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Merger/Acquisition Completed Generating Revenue
To view Ababax’s complete valuation and funding history, request access »

Ababax Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Ababax Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4402688-A1 A computing system for treatment of a neural disorder Pending 15-Sep-2021
US-20240374863-A1 A computing system for treatment of a neural disorder Pending 15-Sep-2021

Ababax Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ababax Investments (1)

Ababax’s most recent deal was a Early Stage VC with Dopavision for . The deal was made on 14-Jul-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Dopavision 14-Jul-2021 Early Stage VC Therapeutic Devices
To view Ababax’s complete investments history, request access »

Ready to get started?

Request a free trial

Ababax Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Neuraltrain Berlin, Germany 2017

Ababax FAQs

  • When was Ababax founded?

    Ababax was founded in 2019.

  • Where is Ababax headquartered?

    Ababax is headquartered in Berlin, Germany.

  • What is the size of Ababax?

    Ababax has 7 total employees.

  • What industry is Ababax in?

    Ababax’s primary industry is Drug Delivery.

  • Is Ababax a private or public company?

    Ababax is a Private company.

  • What is Ababax’s current revenue?

    The current revenue for Ababax is .

  • Who acquired Ababax?

    Ababax was acquired by Eternity.Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process